Ignite Creation Date:
2026-03-26 @ 3:17 PM
Ignite Modification Date:
2026-03-29 @ 11:49 PM
Study NCT ID:
NCT07342335
Status:
RECRUITING
Last Update Posted:
2026-01-15
First Post:
2026-01-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Breaking Barriers to Research Access
Sponsor:
Organization:
Raw JSON
{'hasResults': False, 'derivedSection': {'miscInfoModule': {'versionHolder': '2026-03-25'}, 'conditionBrowseModule': {'meshes': [{'id': 'D009369', 'term': 'Neoplasms'}]}}, 'protocolSection': {'designModule': {'studyType': 'OBSERVATIONAL', 'designInfo': {'timePerspective': 'CROSS_SECTIONAL', 'observationalModel': 'CASE_ONLY'}, 'enrollmentInfo': {'type': 'ESTIMATED', 'count': 300}, 'patientRegistry': False}, 'statusModule': {'overallStatus': 'RECRUITING', 'startDateStruct': {'date': '2024-11-29', 'type': 'ACTUAL'}, 'expandedAccessInfo': {'hasExpandedAccess': False}, 'statusVerifiedDate': '2026-01', 'completionDateStruct': {'date': '2026-11-30', 'type': 'ESTIMATED'}, 'lastUpdateSubmitDate': '2026-01-08', 'studyFirstSubmitDate': '2026-01-08', 'studyFirstSubmitQcDate': '2026-01-08', 'lastUpdatePostDateStruct': {'date': '2026-01-15', 'type': 'ACTUAL'}, 'studyFirstPostDateStruct': {'date': '2026-01-15', 'type': 'ACTUAL'}, 'primaryCompletionDateStruct': {'date': '2026-05-31', 'type': 'ESTIMATED'}}, 'outcomesModule': {'primaryOutcomes': [{'measure': 'Research Barrier Perception and Research Facilitator Perception', 'timeFrame': '12 Months', 'description': 'The primary outcome measures for the questionnaire portion of the study are the overall scores on Research Barrier Perception (RBP: Questions 7 - 11) and Research Facilitator Perception (RFB: Questions 13 - 17). The predictor variable is deprivation, as measured by the IMD, 2019.'}], 'secondaryOutcomes': [{'measure': 'Sub-scores of the Research Participation Questionnaire and are Treatment Perception Scores, Practical Consideration Scores Trust scores, Information scores and Impact scores, and their relationship with deprivation', 'timeFrame': '12 Months', 'description': 'The secondary outcomes relate to the sub-scores of the Research Participation Questionnaire and are Treatment Perception Scores, Practical Consideration Scores Trust scores, Information scores and Impact scores, and their relationship with deprivation (IMD, 2019) will be assessed using a multivariate regression analysis.'}]}, 'oversightModule': {'isFdaRegulatedDrug': False, 'isFdaRegulatedDevice': False}, 'conditionsModule': {'keywords': ['Research Barriers'], 'conditions': ['Cancer']}, 'descriptionModule': {'briefSummary': 'There is a need to improve accessibility to research and clinical trials within the NHS. Key groups are consistently under-represented in research: those from minority ethnic backgrounds, those with lower socio-economic status and those with impaired capacity. This leads to inequality of healthcare and an inequality of patient experience. Increasing access to research would not only broaden research opportunities and bridge gaps in health equality; diverse research representation means better understanding of disease mechanisms and greater generalisability of findings across the patient population. There are well described socio-economic issues across the region that we serve within Cheshire and Merseyside. This brings health challenges for patients. Clatterbridge Cancer Centre is a large networked cancer centre serving Cheshire and Merseyside using a hub model. Research is a core strategic theme; it is hugely important that we understand not only the areas and hotspots of cancer across the region, but also that our patients with those cancers can access a portfolio of research that serves a distinct patient need. Currently there is a lack of such triangulated information within the Trust, which may mean that patient need remains unmet. Therefore the research is designed to understand any barriers that patients may have in accessing research, in tandem with a demographic review and mapping of patient referral and access to the current trials portfolio. This will lead to a truly patient centred approach in accessing research.'}, 'eligibilityModule': {'sex': 'ALL', 'stdAges': ['ADULT', 'OLDER_ADULT'], 'minimumAge': '18 Years', 'samplingMethod': 'NON_PROBABILITY_SAMPLE', 'studyPopulation': 'A wide range of participants will be approached, in terms of age, location, disease site and demographics to give a fair reflection of the patient population', 'healthyVolunteers': False, 'eligibilityCriteria': "Inclusion Criteria:\n\n* Adults over 18 years. No upper age limit\n* A confirmed diagnosis of cancer\n* Patient planned to or is receiving treatment at The Clatterbridge Cancer Centre NHS Foundation Trust\n* Able to provide informed consent\n\nExclusion Criteria:\n\n* Patients with severe co-morbidities considered by the screening team to interfere with the individual's ability to complete requirements of the study or to provide informed consent."}, 'identificationModule': {'nctId': 'NCT07342335', 'briefTitle': 'Breaking Barriers to Research Access', 'organization': {'class': 'OTHER', 'fullName': 'The Clatterbridge Cancer Centre NHS Foundation Trust'}, 'officialTitle': 'Understanding and Breaking Barriers to Research Access for Cancer Patients', 'orgStudyIdInfo': {'id': 'C1337'}, 'secondaryIdInfos': [{'id': '321327', 'type': 'OTHER', 'domain': 'IRAS'}]}, 'contactsLocationsModule': {'locations': [{'zip': 'L7 8YA', 'city': 'Liverpool', 'status': 'RECRUITING', 'country': 'United Kingdom', 'contacts': [{'name': 'Emma Whitby', 'role': 'CONTACT', 'email': 'emma.whitby1@nhs.net', 'phone': '0151 318 8291'}], 'facility': 'Clatterbridge Cancer Centre', 'geoPoint': {'lat': 53.41058, 'lon': -2.97794}}]}, 'ipdSharingStatementModule': {'ipdSharing': 'NO'}, 'sponsorCollaboratorsModule': {'leadSponsor': {'name': 'The Clatterbridge Cancer Centre NHS Foundation Trust', 'class': 'OTHER'}, 'responsibleParty': {'type': 'SPONSOR'}}}}